Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient

被引:6
|
作者
Wandeler, Gilles [1 ,2 ]
Furrer, Hansjakob [1 ]
Rauch, Andri [1 ]
机构
[1] Univ Bern, Univ Hosp Bern, Univ Clin Infect Dis, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland
关键词
ANTIRETROVIRAL THERAPY; INTEGRASE INHIBITORS; DRUG-RESISTANCE; HIV-2; INDIVIDUALS; SENEGAL; PREDICT;
D O I
10.1097/QAD.0b013e32834cdb89
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2306 / 2308
页数:3
相关论文
共 50 条
  • [41] Persistent prurigo nodularis in HIV-infected patient responsive to antiretroviral therapy with raltegravir
    Motegi, Sei-ichiro
    Kato, Madoka
    Uchiyama, Akihiko
    Yamada, Kazuya
    Shimizu, Akira
    Amano, Hiroo
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2014, 41 (03): : 272 - 273
  • [42] Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation
    Antinori, Andrea
    Trotta, Maria Paolo
    Lorenzini, Patrizia
    Torti, Carlo
    Gianotti, Nicola
    Maggiolo, Franco
    Ceccherini-Silberstein, Francesca
    Nasta, Paolo
    Castogna, Antonella
    De Luca, Andrea
    Mussini, Cristina
    Andreoni, Massimo
    Perno, Carlo Federico
    ANTIVIRAL THERAPY, 2007, 12 (08) : 1175 - 1183
  • [43] PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy
    Morales, Fabian Sierra
    Illingworth, Carlos
    Lin, Kathie
    Agosto, Ivia Rivera
    Powell, Chloe
    Sloane, Jacob A.
    Koralnik, Igor J.
    JOURNAL OF NEUROVIROLOGY, 2017, 23 (05) : 789 - 792
  • [44] Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients
    Benard, Antoine
    Damond, Florence
    Campa, Pauline
    Peytavin, Gilles
    Descamps, Diane
    Lascoux-Combes, Caroline
    Taieb, Audrey
    Simon, Francois
    Autran, Brigitte
    Brun-Vezinet, Francoise
    Chene, Genevieve
    Matheron, Sophie
    AIDS, 2009, 23 (09) : 1171 - 1173
  • [45] Dynamics of Raltegravir Resistance Profile in an HIV Type 2-Infected Patient
    Xu, Li
    Anderson, Jane
    Garrett, Nigel
    Ferns, Bridget
    Wildfire, Adrian
    Cook, Pamela
    Workman, Judith
    Graham, Susan
    Smit, Erasmus
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (08) : 843 - 847
  • [46] PML-IRIS in an HIV-2-infected patient presenting as Bell’s palsy
    Fabian Sierra Morales
    Carlos Illingworth
    Kathie Lin
    Ivia Rivera Agosto
    Chloé Powell
    Jacob A. Sloane
    Igor J. Koralnik
    Journal of NeuroVirology, 2017, 23 : 789 - 792
  • [47] High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy
    Cécile Goujard
    Mayeule Legrand
    Xavière Panhard
    Bertrand Diquet
    Xavier Duval
    Gilles Peytavin
    Isabelle Vincent
    Christine Katlama
    Catherine Leport
    Bénédicte Bonnet
    Dominique Salmon-Céron
    France Mentré
    Anne-Marie Taburet
    Clinical Pharmacokinetics, 2005, 44 : 1267 - 1278
  • [48] Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine
    Nozza, S.
    Bigoloni, A.
    Galli, L.
    Gianotti, N.
    Pogliaghi, M.
    Cossarini, F.
    Salpietro, S.
    Galli, A.
    Della Torre, L.
    Tambussi, G.
    Lazzarin, A.
    Castagna, A.
    INFECTION, 2010, 38 : 22 - 23
  • [49] High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy
    Goujard, U
    Legrand, M
    Panhard, X
    Diquet, B
    Duval, X
    Peytavin, G
    Vincent, I
    Katlama, C
    Leport, C
    Bonnet, B
    Salmon-Céron, D
    Mentré, F
    Taburet, AM
    CLINICAL PHARMACOKINETICS, 2005, 44 (12) : 1267 - 1278
  • [50] Antiretroviral therapy containing raltegravir in HIV-infected pregnant women. Systematic review
    Garia-Fernandez, Lisset
    Fiestas, Fabian
    Vasquez, Ruben
    Benites, Carlos
    REVISTA CHILENA DE INFECTOLOGIA, 2016, 33 : S60 - S66